dockets

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5,000 rows where agency_id = "FDA" sorted by last_modified descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: last_modified (date)

docket_type 2

agency_id 1

  • FDA · 5,000 ✖
id agency_id title docket_type last_modified ▲ object_id
FDA-1991-N-0191 FDA Civil money penalties:biologics, drugs and medical devices Nonrulemaking 2026-02-27T22:02:58Z 0b0000648052de46
FDA-2000-M-0083 FDA DACS SC Kit (Density Gradient Separation Medium) Nonrulemaking 2026-02-27T15:28:34Z 0b000064804b8053
FDA-2000-C-0236 FDA Sodium Copper Chlorophyllin to Color Citrus Base Dry Beverage Mixes Nonrulemaking 2026-02-24T15:58:14Z 0b000064804d5895
FDA-2000-N-0012 FDA Request for Samples & Protocols; Agency Information Collection Activities Nonrulemaking 2026-02-24T15:55:19Z 0b000064804ae876
FDA-2000-M-0120 FDA PMA Defender II Model 9201 Implantable Cardioverter Defibrilator Nonrulemaking 2026-02-24T14:46:29Z 0b000064804cf289
FDA-2000-N-0046 FDA Importer's Entry Notice; Agency Information Collection Activities Nonrulemaking 2026-02-24T14:43:05Z 0b000064804af15b
FDA-1981-N-0044 FDA HYDROGEN PEROXIDE AS GRAS Nonrulemaking 2026-02-24T14:29:07Z 0b000064805af2fb
FDA-1997-S-0006 FDA Dietary Supplements, Courtesy Letters (Letters of Objection) Nonrulemaking 2026-02-20T19:22:56Z 0b000064805c957d
FDA-2004-N-0451 FDA Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards Nonrulemaking 2026-02-19T15:23:46Z 0b0000648047540d
FDA-2000-D-0104 FDA Conjugated Estrogens,USP-LC-MS Method for Qualitative Chemical Nonrulemaking 2026-02-17T14:20:25Z 0b000064804c23c0
FDA-2000-F-0166 FDA Components of Paper & Paperboard Incontact with Aqueous An Nonrulemaking 2026-02-17T11:53:41Z 0b000064804d233a
FDA-2000-F-0056 FDA "Inhibitor of yeast", for the Safe of (DMDC) Nonrulemaking 2026-02-17T11:48:23Z 0b000064804af591
FDA-2000-F-0201 FDA Olestra Be Amended Requirement for Label Statement Nonrulemaking 2026-02-13T18:08:59Z 0b000064804d47b7
FDA-2000-V-1390 FDA Request for Variance for Laser Light Show Nonrulemaking 2026-02-13T18:04:52Z 0b000064804f0e42
FDA-2000-F-0055 FDA Safe Use for X-Radiation & Electron Beam Energy Sources Nonrulemaking 2026-02-13T15:47:36Z 0b000064804af54b
FDA-2000-P-0184 FDA Totally Implanted Spinal Cord Stimulator Nonrulemaking 2026-02-13T15:44:16Z 0b000064804d2a90
FDA-2000-D-0067 FDA Medical Device Patient Labeling Nonrulemaking 2026-02-13T15:32:46Z 0b000064804afceb
FDA-1981-N-0029 FDA Sodium Chloride GRAS Safety Nonrulemaking 2026-02-09T20:56:08Z 0b000064805af08d
FDA-1985-P-0507 FDA ANDA SUIT RE: DIAZEPAM INTENSOL 5MG PER ML-CLOSED Nonrulemaking 2026-02-09T15:46:15Z 0b000064805b79a1
FDA-2003-D-0431 FDA Current Good Manufacturing Practices for Medical Gases Nonrulemaking 2026-02-03T20:46:43Z 0b000064804a2255
FDA-1995-S-0036 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 Rulemaking 2026-02-03T17:37:09Z 0b0000648055af86
FDA-2000-P-0211 FDA Amend the Product Insert and/or Label for Anthrax Vaccine Adsorbed Nonrulemaking 2026-02-03T15:25:23Z 0b000064804d4c7c
FDA-2000-N-0222 FDA Dietary Supplement Health Claim/Implementation of Pearson Court Decision Nonrulemaking 2026-01-30T18:32:47Z 0b000064804d51a5
FDA-2000-P-0756 FDA ANADA Consisting of Different Physical Form of Drug Products Nonrulemaking 2026-01-30T18:22:34Z 0b000064804e78ce
FDA-2000-P-0152 FDA Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization Nonrulemaking 2026-01-30T15:29:13Z 0b000064804d1186
FDA-2000-P-0414 FDA Prozac (Fluoxetine Hydrochloride) 20 mg Tablets Voluntarily Withdrawn Nonrulemaking 2026-01-30T15:25:11Z 0b000064804daeec
FDA-2000-M-0203 FDA P990016; McCue CUBA Clinical Ultrasonic Bone Sonometry System Nonrulemaking 2026-01-30T14:58:36Z 0b000064804d49d5
FDA-2000-P-1064 FDA To Amend 21 CFR 107 Subpart B, Labeling of Infant Formulas Nonrulemaking 2026-01-26T14:08:58Z 0b000064804ecd04
FDA-2000-N-0048 FDA Technical Implementation of Electronic Records & Electronic Signatures Nonrulemaking 2026-01-23T14:19:52Z 0b000064804af199
FDA-2000-N-0165 FDA Parasitic Infections in United States as Result of Raw Fish Consumption Nonrulemaking 2026-01-23T14:16:11Z 0b000064804d22bf
FDA-2000-N-1571 FDA Status of Useful Written Prescription Drug Information for Patients Nonrulemaking 2026-01-23T13:56:21Z 0b00006480509235
FDA-2004-P-0153 FDA Modification of 21 CFR Pt. 101.93 to Include Structure/Function ClaIms with Disclaimers that Eliminate Perceived Disease Connotations. Nonrulemaking 2026-01-22T14:14:09Z 0b0000648046fff3
FDA-1999-D-2955 FDA Impurities: Residual Solvents in New Veterinary Medicinal Nonrulemaking 2026-01-21T15:43:17Z 0b000064804f26ac
FDA-2000-D-0420 FDA Potency Limits for Standardized Dust Mite & Grass Nonrulemaking 2026-01-13T14:10:40Z 0b000064804db107
FDA-2000-D-0160 FDA M4 Common Technical Document; International Conference on Harmonisation Nonrulemaking 2026-01-13T11:35:39Z 0b000064804d1829
FDA-2005-D-0460 FDA Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act Nonrulemaking 2026-01-08T15:22:32Z 0b00006480450aea
FDA-2000-P-0183 FDA Request that FDA Not Approve Upjohn's Bovine Growth Hormone Nonrulemaking 2026-01-06T18:45:26Z 0b000064804d2a11
FDA-2000-V-1073 FDA Class IIIb requirements for the IZLID Series Laser Products Nonrulemaking 2026-01-02T18:32:43Z 0b000064804ed086
FDA-2006-P-0207 FDA Petition for Review of Codex Standard for Honey Under 21 CFR 130.6 - OPEN Nonrulemaking 2026-01-02T14:33:19Z 0b0000648045151f
FDA-2003-D-0143 FDA Part11, Electronic records, electronic signatures scope Nonrulemaking 2026-01-02T14:31:51Z 0b00006480486504
FDA-1998-D-0019 FDA Investigating out of Specification(OOS)Test Results fr Pharm Nonrulemaking 2026-01-02T14:26:42Z 0b00006480563cc6
FDA-2000-F-0115 FDA Stabilizer in Olefin Polymers/Safe Use in Food Contact Nonrulemaking 2025-12-19T13:47:19Z 0b000064804cf0d1
FDA-2000-N-0606 FDA Psychiatric & Behavioral Disturbances Associated w/Dementia Nonrulemaking 2025-12-19T13:31:02Z 0b000064804dd979
FDA-2000-N-0162 FDA Amendment of Regulations Regarding Certain Label Statement of Prescription Drugs Nonrulemaking 2025-12-19T13:21:00Z 0b000064804d1924
FDA-2000-D-0155 FDA Reprocessing & Reuse of Single-Use Devices/Risk Categorization Nonrulemaking 2025-12-16T14:25:22Z 0b000064804d14c1
FDA-2000-N-0191 FDA Reclassification of the Knee Joint Patellofemorotibal Metal Nonrulemaking 2025-12-16T12:26:32Z 0b000064804d41a2
FDA-2000-N-0106 FDA Exemption from Federal Preemption of State & Local Medical Nonrulemaking 2025-12-10T17:47:22Z 0b000064804c2509
FDA-1999-P-0001 FDA Reclassification and Codification of Absorbable Polydioxanone Surgical Suture Nonrulemaking 2025-12-09T13:24:03Z 0b000064804a58b4
FDA-1999-V-4085 FDA Variance Laser Light Show Nonrulemaking 2025-12-08T18:16:18Z 0b000064804f5ecd
FDA-1999-P-1852 FDA Foods Derived from New Plant Varieties Nonrulemaking 2025-12-08T14:11:39Z 0b000064804e7408
FDA-2000-N-0108 FDA Safety Reporting Requirements Human Drug/Biological Products - CLOSED Rulemaking 2025-12-03T18:08:26Z 0b000064804c262a
FDA-1999-D-0170 FDA Health Claims for Conventional Foods & Dietary Supplements Nonrulemaking 2025-12-02T14:33:32Z 0b000064804b039e
FDA-1992-V-0040 FDA Laser effects for 'Fantasmic' show; CLOSED Nonrulemaking 2025-11-20T16:05:21Z 0b00006480528933
FDA-1999-D-0045 FDA Transmission of Zoonoses by Blood & Blood Products Nonrulemaking 2025-11-18T17:42:41Z 0b000064804a5f5b
FDA-1999-P-0040 FDA Amend limit Hydrogenated & partially Hydrogenated Menhaden Oil Nonrulemaking 2025-11-18T14:53:35Z 0b000064804a5d9b
FDA-1999-F-4617 FDA Food Safety & Inspection Service Safe Use of Ionizing Radiai Nonrulemaking 2025-11-18T14:17:27Z 0b000064804f7562
FDA-1986-P-0035 FDA EXCLUSIVE RIGHT TO DEPAKOTE (DIVALPROEX SODIUM)-CLOSED Nonrulemaking 2025-11-06T14:10:33Z 0b0000648050e5c0
FDA-1999-E-0090 FDA Patent Term Extension Application for Isolex 300 and ISOLEX 300i, U.S. Patent No. 4,714,680 Nonrulemaking 2025-11-04T18:21:28Z 0b000064804a6a80
FDA-1999-E-0123 FDA Patent Term Extension for Uvadex, U.S. Patent No. 4,999,375 Nonrulemaking 2025-11-04T18:17:51Z 0b000064804ae990
FDA-1999-F-4619 FDA Rubber Articles Intended for Use In Contact With Food Nonrulemaking 2025-11-04T18:03:59Z 0b000064804f78db
FDA-1999-N-4097 FDA Removal of Designed Journals Companion Document Nonrulemaking 2025-10-28T14:21:33Z 0b000064804f5fc5
FDA-1999-N-0195 FDA Amendment of Various Device Regulations Nonrulemaking 2025-10-28T14:17:42Z 0b000064804b04fa
FDA-1999-P-0151 FDA ANDA Suitability Petitions for Parenteral Drugs Nonrulemaking 2025-10-28T12:49:14Z 0b000064804af144
FDA-1999-P-0127 FDA ANDA for Sterile Cefuroxime Sodium, USP Nonrulemaking 2025-10-24T16:18:53Z 0b000064804aea02
FDA-1999-N-1323 FDA Redacted Version of Substantially-Equivalent Premarket Notification Nonrulemaking 2025-10-21T13:43:12Z 0b000064804db076
FDA-1999-P-4069 FDA ANDA for Naltrexone Hydrochloride Yablets for 25 100, &150mg Nonrulemaking 2025-10-21T13:09:35Z 0b000064804f5e3f
FDA-1999-A-4057 FDA Advisory Opinion Oxine(stabilized Chlorine Dioxide) in Sweetwater Systems Nonrulemaking 2025-10-10T13:57:44Z 0b000064804f572f
FDA-1999-P-4073 FDA ANDA for Propoxyphene Napsylate and Acetaminophen Tablets/Capsules 50mg Nonrulemaking 2025-10-10T13:10:26Z 0b000064804f5e65
FDA-1994-N-0415 FDA Proposal to Debar Robert E. Sacher, Ph.D. Nonrulemaking 2025-10-09T13:48:00Z 0b0000648050882a
FDA-1999-P-2918 FDA Extend the Implementation Dates of the OTC Drug Labeling Rules Nonrulemaking 2025-10-07T16:14:50Z 0b000064804f2302
FDA-1999-D-0062 FDA New Use Food Contact Substance Notification Systems-Toxicolology Nonrulemaking 2025-10-07T11:13:07Z 0b000064804a677c
FDA-1999-D-0066 FDA Sampling & Microbial Testing of Spent Irrigation Water Nonrulemaking 2025-09-30T12:59:56Z 0b000064804a67c4
FDA-2002-D-0188 FDA Nonclinical Studies for Development of Pharmaceutical Excipi Nonrulemaking 2025-09-24T16:24:59Z 0b000064804957bb
FDA-1995-N-0389 FDA Fredrick Jay Shainfeld; Debarment Order Nonrulemaking 2025-09-24T16:24:23Z 0b0000648059a4c9
FDA-1998-D-0038 FDA Microbial Effects of Antimicrobial New Animal Drugs/Human Safety Nonrulemaking 2025-09-23T12:57:57Z 0b00006480565cb1
FDA-2005-P-0280 FDA To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations Nonrulemaking 2025-09-23T12:35:31Z 0b00006480444a54
FDA-1999-F-0077 FDA Safe Use of Solid Solution Nonrulemaking 2025-09-23T11:20:23Z 0b000064804a68d2
FDA-1999-F-0056 FDA National Fisheries Institute and the Louisiana Department of Agriculture Nonrulemaking 2025-09-23T11:15:54Z 0b000064804a61b4
FDA-2000-D-0100 FDA Clinical Data In Marketing Applications Nonrulemaking 2025-09-22T15:08:05Z 0b000064804c2118
FDA-2003-D-0145 FDA Draft Guidance: Sterile Drug Products Produced by Aseptic Processing Nonrulemaking 2025-09-17T19:57:00Z 0b00006480486926
FDA-1999-M-0121 FDA PMA Medtronic Hancock II Bioprosthetic Heart Valve, Models T505, T510 & P980043 Nonrulemaking 2025-09-16T17:03:16Z 0b000064804ae967
FDA-1998-P-0083 FDA Withdrawn From Sale of Tylosterone Tablets Nonrulemaking 2025-09-10T18:33:30Z 0b00006480584ac8
FDA-2004-P-0212 FDA request the Commissioner of Food and Drugs to amend 21 CFR, Part 5.10) to request the Commissioner of Food and Drugs to amend 21 CFR, Part 101,subpart C: specific nutrition labeling requirements and guidelines, specifically nutrition labeling of dietary supplements 101.36(d)(1), to require the source of the dietary ingredient lycopene to be indentified as from tomato,fungus, or synthetic Nonrulemaking 2025-09-10T14:20:50Z 0b000064804710ac
FDA-1999-H-0071 FDA Civil Money Penalty; Dong Seo Shin d/b/a East 4th Avenue Food Mart Nonrulemaking 2025-09-09T18:05:21Z 0b000064804a6879
FDA-1999-N-0031 FDA Positron Emmission Tomography Drug Products Nonrulemaking 2025-09-05T13:51:16Z 0b000064804a5cdd
FDA-1999-P-2947 FDA Determine if Neurontin (Gabapentin) Tablets 600mg & 800 Have Withdrawn Nonrulemaking 2025-09-02T15:56:04Z 0b000064804f2668
FDA-1999-V-2946 FDA Laser Light Show Mobolazer Nonrulemaking 2025-09-02T14:26:18Z 0b000064804f2660
FDA-1999-P-0042 FDA Health Claim: Folic Acid, Vitamin B6 etc. & Vascular Disease Nonrulemaking 2025-09-02T10:56:24Z 0b000064804a5e45
FDA-1999-F-0020 FDA Benzenepropanoic Acid, 3-5-bis(1,1-dimethylethy)-4-hydroxy- Nonrulemaking 2025-08-29T13:57:43Z 0b000064804a5ab2
FDA-1999-F-0019 FDA Tridecanol Phosphite Butylidenebis[2-(1,-dimethylethy)-5-met Nonrulemaking 2025-08-29T13:54:21Z 0b000064804a5aa1
FDA-2002-D-0223 FDA Information for the use of Human Blood & Blood Components Nonrulemaking 2025-08-28T17:04:27Z 0b00006480497176
FDA-1999-F-0102 FDA Safe Use of Piperylene/2-methyl-2-butene/alpha-methylstyrene Terpolymers Use in Preparation of Can End Cements / Food Contact Nonrulemaking 2025-08-26T13:11:30Z 0b000064804ae532
FDA-2001-D-0197 FDA Statistical Approaches Establishing Bioequivalence Nonrulemaking 2025-08-15T13:34:50Z 0b000064804e3068
FDA-2002-N-0325 FDA Canned Tomatoes Deviating from Identity Standard Nonrulemaking 2025-08-14T14:35:19Z 0b000064804a0b67
FDA-2005-P-0319 FDA Withhold Approval of any ANDA or any 505(b)(2) Application for any Generic Version or Other Pharmaceutical Alternative of Venofer(Iron Sucrose Injection, USP) Nonrulemaking 2025-08-08T15:50:15Z 0b00006480447df4
FDA-2000-Q-0914 FDA Notification for Health Claims:Potassium Containing Foods Nonrulemaking 2025-08-08T12:10:26Z 0b000064804e8b31
FDA-2000-F-0147 FDA Safe use of ozone in gaseous & aqueous phases as antimicrobi Nonrulemaking 2025-08-08T12:09:19Z 0b000064804d0f8c
FDA-1999-N-1876 FDA Blood Establishment Registration & Product Listing Form 2830 Nonrulemaking 2025-08-07T18:25:12Z 0b000064804e767e
FDA-1999-F-2413 FDA Irradiate Animal Feeds/Feed Ingredients for Microbial Control Nonrulemaking 2025-08-01T18:10:18Z 0b000064804f01c2
FDA-1999-P-0091 FDA Adopt A Policy of Publicizing on the internet Certain Information Nonrulemaking 2025-08-01T16:35:47Z 0b000064804a6a8d

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE dockets (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    title TEXT,
    docket_type TEXT,
    last_modified TEXT,
    object_id TEXT
);
CREATE INDEX idx_dockets_agency ON dockets(agency_id);
CREATE INDEX idx_dockets_type ON dockets(docket_type);